Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Monash IVF Group Ltd ( (AU:MVF) ) has provided an update.
Monash IVF Group Limited has revised its profit guidance for the fiscal year ending June 2025, now expecting an underlying NPAT of approximately $27.5 million, down from the previously anticipated $30.0 million to $31.0 million. This adjustment is due to softer market and operating conditions experienced in March and April 2025, although some recovery was noted in May. The company is also monitoring potential impacts from a recent incident in Brisbane, which could affect patient registrations and other operational metrics.
The most recent analyst rating on (AU:MVF) stock is a Buy with a A$1.55 price target. To see the full list of analyst forecasts on Monash IVF Group Ltd stock, see the AU:MVF Stock Forecast page.
More about Monash IVF Group Ltd
Monash IVF Group Limited operates in the healthcare industry, specializing in fertility services. The company provides a range of assisted reproductive technologies and related services, focusing on IVF treatments and fertility diagnostics across various geographic markets.
Average Trading Volume: 2,184,461
Technical Sentiment Signal: Sell
Current Market Cap: A$331.2M
Learn more about MVF stock on TipRanks’ Stock Analysis page.